pitrakinra — التعريف

Pitrakinra is a recombinant human protein that blocks interlökin-4 (IL-4) and interlökin-13 (IL-13). It was developed to be used in the treatment of allergic inflammatory diseases such as as asthma and atopic dermatitis. ويقلل هذا المخدّر من الحساسية المفرطة وإثارة الطّريق الجوي عن طريق قمع النوع الثاني من الاستجابة المناعية. In clinical studies, it has been shown to be effective in asthma patients with eozinophilic phenotype.